Ola Karmi

1.1k total citations
26 papers, 776 citations indexed

About

Ola Karmi is a scholar working on Molecular Biology, Renewable Energy, Sustainability and the Environment and Rheumatology. According to data from OpenAlex, Ola Karmi has authored 26 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 7 papers in Renewable Energy, Sustainability and the Environment and 3 papers in Rheumatology. Recurrent topics in Ola Karmi's work include RNA modifications and cancer (7 papers), Metalloenzymes and iron-sulfur proteins (7 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Ola Karmi is often cited by papers focused on RNA modifications and cancer (7 papers), Metalloenzymes and iron-sulfur proteins (7 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Ola Karmi collaborates with scholars based in Israel, United States and China. Ola Karmi's co-authors include Rachel Nechushtai, Ron Mittler, Yang Sung Sohn, Itamar Willner, Yu Ouyang, José N. Onuchic, Patricia A. Jennings, Yang‐Sung Sohn, Merav Darash‐Yahana and Henri‐Baptiste Marjault and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and ACS Nano.

In The Last Decade

Ola Karmi

25 papers receiving 774 citations

Peers

Ola Karmi

RESE

PRM

Jingwei Li China

Yuanjie Sun China

Qiaoxia Zhang China

Henri‐Baptiste Marjault Israel

Yulian Wu China

Nuno Penacho Portugal

Haichuan Zhu China

Xiaohui Ling China

Chuanyu Yang China

Rajesh Manne India

Jingwei Li China

Ola Karmi

335 ×0.7

185 ×1.0

RESE

128 ×0.9

19 ×0.1

PRM

80 ×0.7

Citations per year, relative to Ola Karmi Ola Karmi (= 1×) peers Jingwei Li

Countries citing papers authored by Ola Karmi

Since Specialization

Citations

This map shows the geographic impact of Ola Karmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ola Karmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ola Karmi more than expected).

Fields of papers citing papers by Ola Karmi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ola Karmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ola Karmi. The network helps show where Ola Karmi may publish in the future.

Co-authorship network of co-authors of Ola Karmi

This figure shows the co-authorship network connecting the top 25 collaborators of Ola Karmi. A scholar is included among the top collaborators of Ola Karmi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ola Karmi. Ola Karmi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Karmi, Ola, et al.. (2025). Unraveling the molecular mechanism underlying the anticancer activity of CISD2/NAF-144−67. Cancer Letters. 619. 217644–217644.

Nechushtai, Rachel, Ola Karmi, Henri‐Baptiste Marjault, et al.. (2024). CISD3/MiNT is required for complex I function, mitochondrial integrity, and skeletal muscle maintenance. Proceedings of the National Academy of Sciences. 121(22). e2405123121–e2405123121. 9 indexed citations

Ouyang, Yu, Ola Karmi, Yang Sung Sohn, et al.. (2024). Spatially Localized Entropy-Driven Evolution of Nucleic Acid-Based Constitutional Dynamic Networks for Intracellular Imaging and Spatiotemporal Programmable Gene Therapy. Journal of the American Chemical Society. 146(30). 20685–20699. 29 indexed citations

Karmi, Ola, et al.. (2024). Induction of apoptosis by double-stranded RNA was present in the last common ancestor of cnidarian and bilaterian animals. PLoS Pathogens. 20(7). e1012320–e1012320. 2 indexed citations

Marjault, Henri‐Baptiste, Ola Karmi, Lauren J. Webb, et al.. (2023). A combination of a cell penetrating peptide and a protein translation inhibitor kills metastatic breast cancer cells. Cell Death Discovery. 9(1). 325–325. 4 indexed citations

Ouyang, Yu, Michael Fadeev, Pu Zhang, et al.. (2022). Aptamer-Modified Au Nanoparticles: Functional Nanozyme Bioreactors for Cascaded Catalysis and Catalysts for Chemodynamic Treatment of Cancer Cells. ACS Nano. 16(11). 18232–18243. 85 indexed citations

Ouyang, Yu, Michael Fadeev, Pu Zhang, et al.. (2022). Aptamer-Functionalized Ce⁴⁺-Ion-Modified C-Dots: Peroxidase Mimicking Aptananozymes for the Oxidation of Dopamine and Cytotoxic Effects toward Cancer Cells. ACS Applied Materials & Interfaces. 14(50). 55365–55375. 21 indexed citations

Sohn, Yang Sung, Alfredo E. Cárdenas, Ola Karmi, et al.. (2022). A peptide-derived strategy for specifically targeting the mitochondria and ER of cancer cells: a new approach in fighting cancer. Chemical Science. 13(23). 6929–6941. 17 indexed citations

Marjault, Henri‐Baptiste, Ola Karmi, Dorit Michaeli, et al.. (2022). An anti-diabetic drug targets NEET (CISD) proteins through destabilization of their [2Fe-2S] clusters. Communications Biology. 5(1). 437–437. 10 indexed citations

10.

Fischer, Amit, Yu Ouyang, Yang Sung Sohn, et al.. (2022). DNA‐Tetrahedra Corona‐Modified Hydrogel Microcapsules: “Smart” ATP‐ or microRNA‐Responsive Drug Carriers. Small. 18(52). e2204108–e2204108. 28 indexed citations

11.

Zhang, Pu, Amit Fischer, Yu Ouyang, et al.. (2022). Biocatalytic cascades and intercommunicated biocatalytic cascades in microcapsule systems. Chemical Science. 13(25). 7437–7448. 15 indexed citations

12.

Karmi, Ola, et al.. (2021). Disrupting CISD2 function in cancer cells primarily impacts mitochondrial labile iron levels and triggers TXNIP expression. Free Radical Biology and Medicine. 176. 92–104. 30 indexed citations

13.

Karmi, Ola, Yang‐Sung Sohn, Henri‐Baptiste Marjault, et al.. (2021). A Combined Drug Treatment That Reduces Mitochondrial Iron and Reactive Oxygen Levels Recovers Insulin Secretion in NAF-1-Deficient Pancreatic Cells. Antioxidants. 10(8). 1160–1160. 11 indexed citations

14.

Nechushtai, Rachel, Ola Karmi, Henri‐Baptiste Marjault, et al.. (2020). The balancing act of NEET proteins: Iron, ROS, calcium and metabolism. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1867(11). 118805–118805. 52 indexed citations

15.

Chen, Wei‐Hai, Ola Karmi, Bilha Willner, Rachel Nechushtai, & Itamar Willner. (2019). Thrombin Aptamer-Modified Metal–Organic Framework Nanoparticles: Functional Nanostructures for Sensing Thrombin and the Triggered Controlled Release of Anti-Blood Clotting Drugs. Sensors. 19(23). 5260–5260. 19 indexed citations

16.

Karmi, Ola, Henri‐Baptiste Marjault, Luca Pesce, et al.. (2018). The unique fold and lability of the [2Fe-2S] clusters of NEET proteins mediate their key functions in health and disease. JBIC Journal of Biological Inorganic Chemistry. 23(4). 599–612. 49 indexed citations

17.

Karmi, Ola, Sarah H. Holt, Luhua Song, et al.. (2017). Interactions between mitoNEET and NAF-1 in cells. PLoS ONE. 12(4). e0175796–e0175796. 40 indexed citations

18.

Holt, Sarah H., Merav Darash‐Yahana, Yang Sung Sohn, et al.. (2015). Activation of apoptosis in NAF-1-deficient human epithelial breast cancer cells. Journal of Cell Science. 129(1). 155–165. 51 indexed citations

19.

Karmi, Ola, et al.. (2014). The Control of a Carbapenem Resistant Enterobacteriaceae Outbreak at Augusta Victoria Hospital, East Jerusalem Palestine ; Applying CDC Recommendations While Addressing Local Challenges. American Journal of Infection Control. 42(6). S152–S153. 1 indexed citations

20.

Karmi, Ola, et al.. (2011). MEASUREMENT OF VITAMIN B 12 CONCENTRATION: A REVIEW ON AVAILABLE METHODS. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact